Evidence map›Paper›PMID 19193265›Full record

ArticleEmerging infectious diseases2009

Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

Andrew C Steer, Adam Jenney, Joseph Kado, Michael F Good, Michael Batzloff, Lepani Waqatakirewa, E Kim Mullholland, Jonathan R Carapetis

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Burden of invasive group a streptococcus infection in Australia: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2013
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrew C SteerUniversity of Melbourne, Melbourne, Victoria, Australia.
Adam Jenney
Joseph Kado
Michael F Good
Michael Batzloff
Lepani Waqatakirewa
E Kim Mullholland
Jonathan R Carapetis

Funding

Global GAS Vaccine Based On The M-ProteinU01AI060579 · NIAID · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI GOOD, MICHAEL F · 2004 to 2008
$2.8M
NIAID NIH HHS U01 AI060579NIAID NIH HHS U01AI60579
6 · The paper itself

Abstract

We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease in Fiji over a 23-month period, 2005-2007. We identified 64 cases of invasive GAS disease, which represents an average annualized all-ages incidence of 9.9 cases/100,000 population per year (95% confidence interval [CI] 7.6-12.6). Rates were highest in those >65 years of age and in those <5 years, particularly in infants, for whom the incidence was 44.9/100,000 (95% CI 18.1-92.5). The case-fatality rate was 32% and was associated with increasing age and underlying coexisting disease, including diabetes and renal disease. Fifty-five of the GAS isolates underwent emm sequence typing; the types were highly diverse, with 38 different emm subtypes and no particular dominant type. Our data support the view that invasive GAS disease is common in developing countries and deserves increased public health attention.

Indexed as

AdolescentAdultAgedAnti-Bacterial AgentsBacterial Typing TechniquesChildChild, PreschoolFemaleFijiHumansIncidenceInfantMaleMiddle AgedPopulation SurveillanceProspective StudiesAnti-Bacterial Agents

Identifiers

PMID19193265
PMCPMC2657613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.